Brian Powl - 14 Aug 2023 Form 3 Insider Report for Kura Oncology, Inc. (KURA)

Role: Chief Commercial Officer
Signature: Teresa Bair, Attorney-in-fact for Brian Powl
Issuer symbol: KURA
Transactions as of: 14 Aug 2023
Transactions value $: $0
Form type: 3
Filing time: 16 Aug 2023, 16:08:36 UTC
Previous filing: 06 Jul 2023
Next filing: 04 Jan 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.